 | Up a level |
Aghdaei, H.A. and Kadijani, A.A. and Sorrentino, D. and Mirzaei, A. and Shahrokh, S. and Balaii, H. and Geraci, M. and Zali, M.R. (2018) An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients. United European Gastroenterology Journal, 6 (7). pp. 1074-1081.
Chaleshi, V. and Tajali, R. and Savabkar, S. and Zali, N. and Mojarad, E.N. and Haghazali, M. and Pasha, S. and Aghdaei, H.A. and Zali, M.R. and Vahedi, M. (2016) Lack of association between NOD2 rs3135500 and IL12b rs1368439 microRNA binding site SNPs and colorectal cancer susceptibility in an Iranian population. MicroRNA, 5 (2). pp. 152-156.
